State Street Corp Orgenesis Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Orgenesis Inc. stock. As of the latest transaction made, State Street Corp holds 67,659 shares of ORGS stock, worth $40,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,659
Previous 88,659
23.69%
Holding current value
$40,595
Previous $44,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ORGS
# of Institutions
18Shares Held
1.63MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA925KShares$555,0670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA288KShares$172,7730.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$75,1350.0% of portfolio
-
Ronit Capital LLP54.2KShares$32,5000.1% of portfolio
-
Northern Trust Corp Chicago, IL40.7KShares$24,4030.0% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $15.3M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...